ESC Asia with APSC and AFC 2019

The trade-off between the risk of ischaemic vs bleeding events may be different between Asian and non-Asian patients, which warrants careful consideration when deciding on the duration of antiplatelet therapy following a percutaneous coronary intervention (PCI), according to a presentation at ESC Asia Congress 2019.

Several Asian studies evaluating different types of valvular heart disease (VHD) reflected poor clinical outcomes, according to a presentation at ESC Asia 2019.

Podcast: Prof Carolyn Lam speaks on the challenges of managing HF in Asia

Podcast: Prof Michel Komajda shares his insights on what the ESC hypertension guidelines mean for Asians

Podcast: Assoc Prof Yeo Khung Keong talks about the hopes and promises of AI in cardiology

The prognosis and the optimal doses of guideline-directed medical therapy (GDMT) for heart failure (HF) appear to be different between men and women, according to leading cardiologist Professor Carolyn Lam from the Duke-National University of Singapore.

Many patients with nonvalvular atrial fibrillation (NVAF) in Thailand use anticoagulants, but the uptake of nonvitamin-K oral anticoagulants remains suboptimal despite showing an upward trend, according to data from the COOL-AF registry presented at the European Society of Cardioloy (ESC) Asia Congress 2019 with APSC and AFC.

Artificial intelligence (AI) is poised to play a major role in cardiology, according to a recent presentation at the Asia Congress of the European Society of Cardiology (ESC Asia) 2019 in Singapore.

Slideshow: Highlights from the ESC Asia with APSC and AFC 2019